These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17395975)

  • 1. Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment.
    Brama M; Basciani S; Cherubini S; Mariani S; Migliaccio S; Arizzi M; Rosano G; Spera G; Gnessi L
    Endocr Relat Cancer; 2007 Mar; 14(1):61-72. PubMed ID: 17395975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo.
    Irsan I; Akisue T; Hara H; Fujimoto T; Imabori M; Doita M; Kuroda R; Fujioka H; Kawamoto T; Yamamoto T; Kurosaka M
    Anticancer Res; 2007; 27(1A):423-9. PubMed ID: 17352263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
    Weigel MT; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Bauer M; Jonat W; Maass N; Mundhenke C
    Cancer Lett; 2009 Jan; 273(1):70-9. PubMed ID: 18809244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
    Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects.
    Rocha A; Azevedo I; Soares R
    J Cell Biochem; 2008 Feb; 103(2):607-14. PubMed ID: 17614352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta.
    Prunotto M; Bosco M; Daniele L; Macri' L; Bonello L; Schirosi L; Rossi G; Filosso P; Mussa B; Sapino A
    Lung Cancer; 2009 May; 64(2):244-6. PubMed ID: 19041155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
    Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
    Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of STI571 on cell proliferation of human malignant fibrous histiocytoma cell lines.
    Kawamoto T; Akisue T; Marui T; Nakatani T; Hitora T; Fujita I; Kurosaka M; Yamamoto T
    Anticancer Res; 2004; 24(5A):2675-9. PubMed ID: 15517872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts.
    Gioni V; Karampinas T; Voutsinas G; Roussidis AE; Papadopoulos S; Karamanos NK; Kletsas D
    Mol Cancer Res; 2008 May; 6(5):706-14. PubMed ID: 18505916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors.
    Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ
    J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
    Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
    Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
    Holdhoff M; Kreuzer KA; Appelt C; Scholz R; Na IK; Hildebrandt B; Riess H; Jordan A; Schmidt CA; Van Etten RA; Dörken B; le Coutre P
    Blood Cells Mol Dis; 2005; 34(2):181-5. PubMed ID: 15727903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T].
    Zhang PY; Li BJ; Su XD; Wen ZS; Zhao JM; Zhang LJ; Long H; Rong TH
    Ai Zheng; 2006 Apr; 25(4):456-60. PubMed ID: 16613680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro.
    Zhang P; Gao WY; Turner S; Ducatman BS
    Mol Cancer; 2003 Jan; 2():1. PubMed ID: 12537587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
    Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Rα/ß expression in squamous cell carcinoma of the head and neck in vitro.
    Schultz JD; Rotunno S; Riedel F; Anders C; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
    Int J Oncol; 2011 Apr; 38(4):1001-12. PubMed ID: 21249316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate.
    Shaw TJ; Vanderhyden BC
    Gynecol Oncol; 2007 Apr; 105(1):122-31. PubMed ID: 17169414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells.
    Kang JX; Liu J; Wang J; He C; Li FP
    Carcinogenesis; 2005 Nov; 26(11):1934-9. PubMed ID: 15958519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.